QURE uniQure NV

Price (delayed)

$21.305

Market cap

$993.83M

P/E Ratio

3.02

Dividend/share

N/A

EPS

$7.06

Enterprise value

$604.35M

uniQure is delivering on the promise of gene therapy - single treatments with potentially curative results. We are leveraging our modular and validated technology platform to rapidly advance a pipeline ...

Highlights
QURE's price to earnings (P/E) is 23% less than its last 4 quarters average of 3.7
The equity has soared by 139% YoY but it is down by 8% QoQ
The quick ratio has soared by 52% year-on-year but it is down by 25% since the previous quarter
The debt rose by 28% YoY
The gross margin is down by 4.8% year-on-year

Key stats

What are the main financial stats of QURE
Market
Shares outstanding
46.65M
Market cap
$993.83M
Enterprise value
$604.35M
Valuations
Price to earnings (P/E)
3.02
Price to book (P/B)
1.81
Price to sales (P/S)
1.89
EV/EBIT
1.8
EV/EBITDA
1.76
EV/Sales
1.15
Earnings
Revenue
$525.34M
EBIT
$335.29M
EBITDA
$342.85M
Free cash flow
$285.9M
Per share
EPS
$7.06
Free cash flow per share
$6.14
Book value per share
$11.75
Revenue per share
$11.27
TBVPS
$14.37
Balance sheet
Total assets
$757.15M
Total liabilities
$211.15M
Debt
$135.41M
Equity
$546M
Working capital
$533.51M
Liquidity
Debt to equity
0.25
Current ratio
12.94
Quick ratio
12.61
Net debt/EBITDA
-1.14
Margins
EBITDA margin
65.3%
Gross margin
95.2%
Net margin
61.8%
Operating margin
55%
Efficiency
Return on assets
41.5%
Return on equity
54.9%
Return on invested capital
161.4%
Return on capital employed
47.1%
Return on sales
63.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

QURE stock price

How has the uniQure stock price performed over time
Intraday
5.52%
1 week
14.3%
1 month
32%
1 year
-25.14%
YTD
2.72%
QTD
14.3%

Financial performance

How have uniQure's revenue and profit performed over time
Revenue
$525.34M
Gross profit
$500.36M
Operating income
$288.73M
Net income
$324.47M
Gross margin
95.2%
Net margin
61.8%
The net margin has soared by 117% YoY
The operating margin has soared by 115% YoY but it has contracted by 3.3% from the previous quarter
The gross margin is down by 4.8% year-on-year
QURE's operating income is down by 3.2% QoQ

Growth

What is uniQure's growth rate over time

Valuation

What is uniQure stock price valuation
P/E
3.02
P/B
1.81
P/S
1.89
EV/EBIT
1.8
EV/EBITDA
1.76
EV/Sales
1.15
QURE's price to earnings (P/E) is 23% less than its last 4 quarters average of 3.7
The equity has soared by 139% YoY but it is down by 8% QoQ
QURE's P/B is 76% below its 5-year quarterly average of 7.3 and 14% below its last 4 quarters average of 2.0
The P/S is 99% lower than the 5-year quarterly average of 145.3 and 22% lower than the last 4 quarters average of 2.3

Efficiency

How efficient is uniQure business performance
The return on equity has surged by 196% year-on-year but it has declined by 15% since the previous quarter
The company's return on sales has surged by 116% YoY
The ROA has contracted by 14% from the previous quarter
The return on invested capital has declined by 9% since the previous quarter

Dividends

What is QURE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QURE.

Financial health

How did uniQure financials performed over time
QURE's total assets has surged by 108% year-on-year but it is down by 6% since the previous quarter
The total liabilities has soared by 56% YoY
The debt is 75% lower than the equity
The equity has soared by 139% YoY but it is down by 8% QoQ
The debt to equity is down by 46% YoY but it is up by 9% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.